Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mayne Distributing Canadian Methotrexate During Shortage

This article was originally published in The Pink Sheet Daily

Executive Summary

Allocation program for the preservative-containing injection uses product labeling written in English and French. The move could have implications for the drug importation debate.

You may also be interested in...

GSK Flu Vaccine To Be Available In U.S. With Informed Consent

Patients using GSK's Fluarix under IND will need to complete an informed consent form. HHS is immediately purchasing 1.2 mil doses of the influenza vaccine, with an option to procure up to 2.8 mil. additional doses.

US FDA’s COVID Whirlwind: Pfizer Vaccine Adcom Set; Monoclonal EUAs Cleared; Trump Aggrieved

Warp Speed’s Slaoui predicts vaccinations starting within days of the 10 December advisory committee for Pfizer’s coronavirus vaccine. Regeneron’s monoclonal cocktail follows Lilly’s antibody product with an EUA.

Pink Sheet Podcast: US FDA In A Biden Administration, Aducanumab’s Adcomm Failure

Pink Sheet reporters and editor discuss the potential changes at the FDA under President-elect Biden and the take-aways from the negative advisory committee recommendation for Biogen’s proposed Alzheimer’s drug aducanumab.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts